Cargando…

Severe renal Fanconi and management strategies in Arthrogryposis-Renal dysfunction-Cholestasis syndrome: a case report

BACKGROUND: Arthrogryposis-Renal dysfunction-Cholestasis syndrome (ARC, MIM#208085) is a rare multisystem disease due to mutations in the VPS33B and VIPAR genes, both involved in maintaining apical-basolateral cell polarity. The correlation between mutations and phenotype in the ARC Syndrome is not...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosales, Alejandra, Mhibik, Maissa, Gissen, Paul, Segarra, Oscar, Redecillas, Susana, Ariceta, Gema
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003143/
https://www.ncbi.nlm.nih.gov/pubmed/29907094
http://dx.doi.org/10.1186/s12882-018-0926-1
_version_ 1783332316589850624
author Rosales, Alejandra
Mhibik, Maissa
Gissen, Paul
Segarra, Oscar
Redecillas, Susana
Ariceta, Gema
author_facet Rosales, Alejandra
Mhibik, Maissa
Gissen, Paul
Segarra, Oscar
Redecillas, Susana
Ariceta, Gema
author_sort Rosales, Alejandra
collection PubMed
description BACKGROUND: Arthrogryposis-Renal dysfunction-Cholestasis syndrome (ARC, MIM#208085) is a rare multisystem disease due to mutations in the VPS33B and VIPAR genes, both involved in maintaining apical-basolateral cell polarity. The correlation between mutations and phenotype in the ARC Syndrome is not well described. We report on a 6 year old patient who presented with severe renal Fanconi as first manifestation of ARC related to a combined de novo mutation in the VPS33B gene. CASE PRESENTATION: A 6 year old girl presented during the first year of life with severe renal Fanconi as the first manifestation of ARC-Syndrome. This case presents all defining features of ARC syndrome (including liver, skin and articular manifestations) with predominantly renal impairment at presentation. This novel mutation may be associated with a pronounced renal phenotype in ARC. Furthermore, we report on the successful use of LDL-Apheresis and biliodigestive derivation for treatment of cholestatic pruritus with encouraging results. CONCLUSION: ARC is a heterogeneous disorder with early mortality. This case report contributes to a better understanding of this rare disorder, describes a novel mutation in the VPS33B gene and presents an innovative rescue treatment approach.
format Online
Article
Text
id pubmed-6003143
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60031432018-07-06 Severe renal Fanconi and management strategies in Arthrogryposis-Renal dysfunction-Cholestasis syndrome: a case report Rosales, Alejandra Mhibik, Maissa Gissen, Paul Segarra, Oscar Redecillas, Susana Ariceta, Gema BMC Nephrol Case Report BACKGROUND: Arthrogryposis-Renal dysfunction-Cholestasis syndrome (ARC, MIM#208085) is a rare multisystem disease due to mutations in the VPS33B and VIPAR genes, both involved in maintaining apical-basolateral cell polarity. The correlation between mutations and phenotype in the ARC Syndrome is not well described. We report on a 6 year old patient who presented with severe renal Fanconi as first manifestation of ARC related to a combined de novo mutation in the VPS33B gene. CASE PRESENTATION: A 6 year old girl presented during the first year of life with severe renal Fanconi as the first manifestation of ARC-Syndrome. This case presents all defining features of ARC syndrome (including liver, skin and articular manifestations) with predominantly renal impairment at presentation. This novel mutation may be associated with a pronounced renal phenotype in ARC. Furthermore, we report on the successful use of LDL-Apheresis and biliodigestive derivation for treatment of cholestatic pruritus with encouraging results. CONCLUSION: ARC is a heterogeneous disorder with early mortality. This case report contributes to a better understanding of this rare disorder, describes a novel mutation in the VPS33B gene and presents an innovative rescue treatment approach. BioMed Central 2018-06-15 /pmc/articles/PMC6003143/ /pubmed/29907094 http://dx.doi.org/10.1186/s12882-018-0926-1 Text en © The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Rosales, Alejandra
Mhibik, Maissa
Gissen, Paul
Segarra, Oscar
Redecillas, Susana
Ariceta, Gema
Severe renal Fanconi and management strategies in Arthrogryposis-Renal dysfunction-Cholestasis syndrome: a case report
title Severe renal Fanconi and management strategies in Arthrogryposis-Renal dysfunction-Cholestasis syndrome: a case report
title_full Severe renal Fanconi and management strategies in Arthrogryposis-Renal dysfunction-Cholestasis syndrome: a case report
title_fullStr Severe renal Fanconi and management strategies in Arthrogryposis-Renal dysfunction-Cholestasis syndrome: a case report
title_full_unstemmed Severe renal Fanconi and management strategies in Arthrogryposis-Renal dysfunction-Cholestasis syndrome: a case report
title_short Severe renal Fanconi and management strategies in Arthrogryposis-Renal dysfunction-Cholestasis syndrome: a case report
title_sort severe renal fanconi and management strategies in arthrogryposis-renal dysfunction-cholestasis syndrome: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003143/
https://www.ncbi.nlm.nih.gov/pubmed/29907094
http://dx.doi.org/10.1186/s12882-018-0926-1
work_keys_str_mv AT rosalesalejandra severerenalfanconiandmanagementstrategiesinarthrogryposisrenaldysfunctioncholestasissyndromeacasereport
AT mhibikmaissa severerenalfanconiandmanagementstrategiesinarthrogryposisrenaldysfunctioncholestasissyndromeacasereport
AT gissenpaul severerenalfanconiandmanagementstrategiesinarthrogryposisrenaldysfunctioncholestasissyndromeacasereport
AT segarraoscar severerenalfanconiandmanagementstrategiesinarthrogryposisrenaldysfunctioncholestasissyndromeacasereport
AT redecillassusana severerenalfanconiandmanagementstrategiesinarthrogryposisrenaldysfunctioncholestasissyndromeacasereport
AT aricetagema severerenalfanconiandmanagementstrategiesinarthrogryposisrenaldysfunctioncholestasissyndromeacasereport